NeuroSigma’s Monarch eTNS System to be Unveiled in London

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch™ eTNS™ system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.

Cook Medical Opens New $19M U.S. Medical Device Manufacturing Plant

This is what targeted investment in a community looks like, as Cook Medical and its parent Cook Group adds a new manufacturing facility to Canton Illinois, having already built one two years ago… and a boutique hotel! Little wonder the company feels it has the moral high ground as it fights the Government’s new medtech tax plans.

- in: Categories ,